ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 584,16
-0,64%
Dow Jones
40 211,72
0,53%
DAX
18 491,84
-0,58%
Brent Oil
83,625
-0,85%
Bitcoin
62 756,41
-3,23%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
21/02/201714h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Fourth Quarter and Year-End 2016 Financial Results and Host Conference Call on Tuesday, F...NASDAQ:PTLAPortola Pharmaceuticals Inc
14/02/201717h47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
14/02/201700h27Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:PTLAPortola Pharmaceuticals Inc
10/02/201717h16Edgar (US Regulatory)Schedule 13gNASDAQ:PTLAPortola Pharmaceuticals Inc
08/02/201714h00GlobeNewswire Inc.FDA Informs Portola Pharmaceuticals at Mid-Cycle Review for Betrixaban That It Has Not Identified Issues that Require an Advi...NASDAQ:PTLAPortola Pharmaceuticals Inc
03/02/201714h42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/02/201714h00GlobeNewswire Inc.Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commerciali...NASDAQ:PTLAPortola Pharmaceuticals Inc
03/01/201714h00GlobeNewswire Inc.Portola Pharmaceuticals to Webcast Corporate Update on January 10, 2017NASDAQ:PTLAPortola Pharmaceuticals Inc
23/12/201620h12GlobeNewswire Inc.Portola Pharmaceuticals Announces FDA Accepts New Drug Application for Priority Review and EMA Validates Marketing Authorizat...NASDAQ:PTLAPortola Pharmaceuticals Inc
19/12/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Enters into $50 Million Loan Agreement with Bristol-Myers Squibb and Pfizer for Continued Development...NASDAQ:PTLAPortola Pharmaceuticals Inc
28/11/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces AndexXa™ (andexanet alfa), Betrixaban and Cerdulatinib Data to be Presented at 2016 Ameri...NASDAQ:PTLAPortola Pharmaceuticals Inc
14/11/201622h15GlobeNewswire Inc.Portola Pharmaceuticals Announces Three Phase 3 APEX Substudy Results Showing Further Benefits of Treating Acute Medically Il...NASDAQ:PTLAPortola Pharmaceuticals Inc
07/11/201623h42Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/11/201622h05GlobeNewswire Inc.Portola Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
07/11/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces New APEX Study Sub-Analyses Data to be Presented at American Heart Association Scientific S...NASDAQ:PTLAPortola Pharmaceuticals Inc
02/11/201613h00GlobeNewswire Inc.Portola Pharmaceuticals to Present at the Credit Suisse 25th Annual Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
01/11/201613h00GlobeNewswire Inc.Portola Pharmaceuticals Expands Clinical Collaboration Agreement with Daiichi Sankyo Worth Up to $25 Million to Develop Andex...NASDAQ:PTLAPortola Pharmaceuticals Inc
31/10/201613h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Third Quarter 2016 Financial Results and Host Conference Call on Monday, November 7NASDAQ:PTLAPortola Pharmaceuticals Inc
25/10/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Submits New Drug Application to U.S. FDA for Betrixaban for Extended Duration Prophylaxis of Venous T...NASDAQ:PTLAPortola Pharmaceuticals Inc
14/10/201600h07GlobeNewswire Inc.Portola Pharmaceuticals Supports “World Thrombosis Day” Campaign to Increase Awareness of Risks of Blood ClotsNASDAQ:PTLAPortola Pharmaceuticals Inc
13/09/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Data Presentations on AndexXa™ (andexanet alfa) at Neurocritical Care Society 2...NASDAQ:PTLAPortola Pharmaceuticals Inc
30/08/201610h01GlobeNewswire Inc.Portola Pharmaceuticals Announces Interim Results from Ongoing Phase 3b/4 ANNEXXA-4™ Study of Factor Xa Inhibitor Antidote ...NASDAQ:PTLAPortola Pharmaceuticals Inc
26/08/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Presentation of Interim Results from Phase 3b/4 ANNEXA™-4 Study of AndexXa™ (andexanet ...NASDAQ:PTLAPortola Pharmaceuticals Inc
19/08/201614h30GlobeNewswire Inc.Portola Pharmaceuticals Announces Validation of Marketing Authorization Application (MAA) by European Medicines Agency (EMA) ...NASDAQ:PTLAPortola Pharmaceuticals Inc
18/08/201604h57GlobeNewswire Inc.Portola Pharmaceuticals Receives Complete Response Letter from FDA for Biologics License Application for AndexXa™ (andexane...NASDAQ:PTLAPortola Pharmaceuticals Inc
09/08/201622h05GlobeNewswire Inc.Portola Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
02/08/201622h05GlobeNewswire Inc.Portola Pharmaceuticals to Announce Second Quarter 2016 Financial Results and Host Conference Call on Tuesday, August 9NASDAQ:PTLAPortola Pharmaceuticals Inc
22/06/201614h20PR Newswire (US)Biotechnology Stocks in Motion -- Minerva Neurosciences, Portola Pharma, Trevena, and Anthera PharmaNASDAQ:PTLAPortola Pharmaceuticals Inc
21/06/201623h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
14/06/201612h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

BOV
CTSA3
SANTANENSE ON
LSE
GLT5
Ivz Glt 1-5 Dst
LSE
TIP5
Ishs $ Tps 0-5
LSE
ATST
Alliance
NASDAQ
AMIX
Autonomix Medical
NASDAQ
NYNY
Empire Resorts
LSE
AEEE
Aquila Energy Efficiency
EU
D401T
D401T
LSE
0JG5
Bittium Oyj
LSE
0MLL
Kulcs Soft Szamitastechn...
LSE
0QJQ
Zeal Network
LSE
0KP1
Proshares Short High Yield
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés